Page last updated: 2024-08-17

triiodothyronine and afimoxifene

triiodothyronine has been researched along with afimoxifene in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albaladejo, V; Andre, J; Joly-Pharaboz, MO; Nicolas, B; Zhou-Li, F	1
Bandiera, SM; Ickenstein, LM	1

Other Studies

2 other study(ies) available for triiodothyronine and afimoxifene

Article	Year
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Endocrinology, 1992, Volume: 130, Issue:3 Topics: Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor I; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Thyroid Hormone; RNA, Messenger; Tamoxifen; Transcription, Genetic; Triiodothyronine; Tumor Cells, Cultured	1992
Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:2 Topics: Animals; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation, Enzymologic; Liver; Organ Size; Ovary; Rats; Rats, Long-Evans; Steroid Hydroxylases; Tamoxifen; Testosterone; Thyroxine; Time Factors; Triiodothyronine; Uterus	2002

Article

Year

Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.

Endocrinology, 1992, Volume: 130, Issue:3

Topics: Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor I; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Thyroid Hormone; RNA, Messenger; Tamoxifen; Transcription, Genetic; Triiodothyronine; Tumor Cells, Cultured

1992

Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate.

The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:2

Topics: Animals; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation, Enzymologic; Liver; Organ Size; Ovary; Rats; Rats, Long-Evans; Steroid Hydroxylases; Tamoxifen; Testosterone; Thyroxine; Time Factors; Triiodothyronine; Uterus

2002